(Q40043107)

16 September 2017

title

Analysis of factor VIII mediated suppression of lentiviral vector titres (English)

1 reference

16 September 2017

Radcliffe PA

1

1 reference

16 September 2017

Sion CJ

2

1 reference

16 September 2017

Wilkes FJ

3

1 reference

16 September 2017

Custard EJ

4

1 reference

16 September 2017

Beard GL

5

1 reference

16 September 2017

Kingsman SM

6

1 reference

16 September 2017

Mitrophanous KA

7

1 reference

16 September 2017

publication date

29 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

15

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

289-297

1 reference

Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Efficient production of human FVIII in hemophilic mice using lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Correction of Bleeding Diathesis Without Liver Toxicity Using Arenaviral-Pseudotyped HIV-1–Based Vectors in Hemophilia A Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

In vitro and in vivo comparative study of chimeric liver-specific promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Generation and characterization of human hematopoietic cell lines expressing factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Gene therapy for the hemophilias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Evaluation of Relative Promoter Strength in Primary Hepatocytes Using Optimized Lipofection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303080

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3303080

1 reference

Dimensions Publication ID

16 September 2017

1025984488

0 references

1 reference